Multiple animal studies including post-infarction models show Thymosin Beta-4 reduces scar tissue formation, promotes cardiomyocyte survival, and supports microvascular regeneration in damaged heart tissue.22 A 2010 study published in Annals of the New York Academy of Sciences showed that Thymosin Beta-4 initiated adult cardiac progenitor cell differentiation and cardiac repair in injured myocardium.23 While direct long COVID RCT data doesn't yet exist for TB-500, the mechanistic overlap with long COVID cardiovascular pathology is strong
Notably, the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial, the first dedicated kidney outcome trial evaluating canagliflozin in people with type 2 diabetes mellitus and CKD, demonstrated a substantial reduction in the risk of kidney events [46]
With its ability to recognise and selectively eliminate senescent cells without damaging the surrounding tissue, FOXO4-DRI is among the molecular tools shaping a new generation of therapeutic approaches focused on anti-aging and regeneration
& Brooks, A
Flow cytometry analysis for Cas12f-reporter assay The Cas12f-reporter cells and EVs were mixed in the 96-well plates, which were incubated for 3 days at 37 C in a humidified atmosphere of 5% CO 2 (described in Cas12f-reporter assay)
Tri-Fortifyalso helps support healthy liver function
